Pictet Asset Management (Switzerland)’s AbbVie ABBV Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$110M	Buy	816,387 +57,469	+8%	+$8.43M	0.13%	184
2023 Q1	$121M	Sell	758,918 -88,556	-10%	-$13.5M	0.15%	178
2022 Q4	$109M	Sell	847,474 -72,507	-8%	-$11.1M	0.16%	177
2022 Q3	$123M	Sell	919,981 -106,186	-10%	-$15.2M	0.18%	167
2022 Q2	$157M	Buy	1,026,167 +129,869	+14%	+$19.8M	0.22%	140
2022 Q1	$145M	Buy	896,298 +80,383	+10%	+$11.7M	0.16%	174
2021 Q4	$110M	Buy	815,915 +19,133	+2%	+$2.26M	0.11%	218
2021 Q3	$85.9M	Buy	+796,782	New	+$91M	0.09%	246

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s ABBV Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its AbbVie (ABBV) stake by 7.6% in Q2 2023, buying an estimated $8.43M and bringing the position to 816,387 shares worth $110M. The position accounts for 0.13% of the portfolio, ranked #184.

Pictet Asset Management (Switzerland) first reported a position in ABBV in Q3 2021 and has held it in 8 quarters since. The position peaked at $157M in Q2 2022. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Pictet Asset Management (Switzerland) held 816,387 shares of AbbVie worth $110M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 57,469 AbbVie shares in Q2 2023, an estimated $8.43M.
AbbVie made up 0.13% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #184 holding.
Pictet Asset Management (Switzerland) first reported a position in AbbVie in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s AbbVie position peaked at $157M in Q2 2022.
3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.